Screener
Eton Pharmaceuticals, Inc. ETON Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | 1,875 | 1,161 |
| General and administrative | 10,446 | 9,170 |
| Total operating expenses | 12,321 | 10,331 |
| Income (loss) from operations | 2,414 | (470) |
| Other expense: | ||
| Interest and other expense, net | (840) | (1,028) |
| Income (loss) before income tax expense | 1,574 | (1,498) |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total operating expenses?
- Eton Pharmaceuticals, Inc. (ETON) reported total operating expenses of $12.32M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total operating expenses increased by 19.3% year-over-year, from $10.33M to $12.32M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s total operating expenses has grown at a 20.7% compound annual growth rate (CAGR), from $20.54M to $43.58M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Eton Pharmaceuticals, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude